you are correct that’s exactly what your assertions are - hypothetical.
you should listen to Dr Nathan Steinle who was intimately involved in Opthea’s early studies who basically highlights the safety as notable and very important.
He also specifically mentioned no IOP was observed. Of course very long term more IOP could develop but your theory is lacking real world evidence.
I also see no issue whatsoever with the trial design or patient selection so I do say “ Bravo Opthea” but not in the sarcastic way you do. In the way that agrees with the significant value inflection seen in the market.
- Forums
- ASX - By Stock
- Is anyone else on here a Doctor or Biomedical researcher (etc)?
you are correct that’s exactly what your assertions are -...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
53.5¢ |
Change
-0.015(2.73%) |
Mkt cap ! $658.6M |
Open | High | Low | Value | Volume |
54.0¢ | 55.0¢ | 53.0¢ | $825.1K | 1.527M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22320 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 112456 | 0.530 |
5 | 97841 | 0.525 |
3 | 60285 | 0.520 |
3 | 80990 | 0.515 |
5 | 90923 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 5000 | 1 |
0.545 | 26231 | 2 |
0.550 | 120920 | 10 |
0.555 | 39285 | 2 |
0.560 | 12023 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |